<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------------------------
FORM 8-K
JOINT CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
JANUARY 28, 2000
MEDITRUST CORPORATION
(Exact Name of Registrant as specified in its charter)
<TABLE>
<CAPTION>
<S> <C> <C>
DELAWARE 0-9109 95-3520818
(State or other jurisdiction (Commission File (I.R.S. Employer
of incorporation) Number) Identification No.)
</TABLE>
197 FIRST AVENUE, SUITE 300, NEEDHAM, MA 02494
(Address of principal executive offices and zip
code)
(781) 433-6000
(Registrant's telephone number, including area code)
MEDITRUST OPERATING COMPANY
(Exact Name of Registrant as specified in its charter)
<TABLE>
<CAPTION>
<S> <C> <C>
DELAWARE 0-9110 95-3419438
(State or other jurisdiction (Commission File (I.R.S. Employer
of incorporation) Number) Identification No.)
</TABLE>
197 FIRST AVENUE, SUITE 100, NEEDHAM, MA 02494
(Address of principal executive offices and zip
code)
(781) 453-8062
(Registrant's telephone number, including area code)
<PAGE>
ITEM 5. OTHER EVENTS
On January 28, 2000 Meditrust Corporation and Meditrust Operating Company
(collectively, the "Companies") disclosed a five point reorganization plan more
fully described in the press release attached hereto as Exhibit 99.1, which
included, among other things, announcement of the departure of David F. Benson
as the chief executive officer, president and treasurer of Meditrust
Corporation. The terms of the cessation of Mr. Benson's employment with
Meditrust Corporation are more fully described in the Termination and Severance
Agreement attached hereto as Exhibit 99.2
The press release attached hereto as Exhibit 99.1 and the Termination and
Severance Agreement attached hereto as Exhibit 99.2 are hereby incorporated by
reference herein.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) EXHIBITS
EXHIBIT NO. DESCRIPTION
99.1 Press release of The Meditrust Companies dated January 28, 2000
announcing its five point plan of reorganization.
99.2 Termination and Severance Agreement, dated January 28, 2000, by
and among Meditrust Corporation, Meditrust Operating Company
and David F.Benson.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: January 31, 2000 MEDITRUST CORPORATION
By: /s/ MICHAEL S. BENJAMIN
-------------------------------
Name: Michael S. Benjamin
Title: Senior Vice President
MEDITRUST OPERATING COMPANY
By: /s/ WILLIAM C. BAKER
---------------------------------
Name: William C. Baker
Title: President
<PAGE>
EXHIBIT 99.1
CONTACT: Joele Frank/Josh Silverman
J. Frank Associates
212-355-4449 ext. 107/121
MEDITRUST ANNOUNCES FIVE POINT PLAN OF REORGANIZATION
Needham, Massachusetts, [January 28, 2000] - The Meditrust Companies (NYSE: MT)
today announced that their boards of directors have approved a five-point plan
of reorganization.
Meditrust's reorganization plan provides for:
- an orderly disposition of a significant portion of its healthcare
assets;
- suspension of its REIT common share dividend;
- expectation of the declaration of the minimum dividend required to
maintain REIT status in December 2000;
- substantial reduction in debt;
- future disciplined investment in lodging division.
The intent of the reorganization plan is to improve the overall financial
condition of Meditrust by substantially deleveraging the Companies. The plan
takes advantage of the Companies' demonstrated ability to sell healthcare
assets and use the proceeds from these sales to repay debt obligations. Also,
the suspension of the dividend will provide additional funds to repay debt
and strengthen the Companies' balance sheet. These actions are also designed
to allow the Companies to make disciplined investments to position its
lodging division to benefit from improving industry trends when the
supply/demand imbalance in its sector begins to moderate.
DIVESTITURE OF HEALTHCARE ASSETS
Consistent with the plan of reorganization, Meditrust intends to implement an
orderly disposition of a significant portion of its healthcare assets. It is
anticipated that the proceeds generated from the sales of these assets will be
used to repay debt and substantially deleverage the Companies' balance sheet. As
of December 31, 1999, Meditrust's healthcare portfolio had a book value of
approximately $2.2 billion. The Companies have generated gross proceeds from the
sale of healthcare assets which have permitted them to repay over $625 million
of term debt. The Companies will not have additional public comment regarding
the potential sales of its healthcare assets until sales have been consummated.
A number of factors have negatively impacted the long-term care and assisted
living sectors of the healthcare industry. These include the federal
government's shift to a Medicare prospective
<PAGE>
payment system in the skilled nursing industry, increased labor costs, fill-up
periods of longer duration for assisted living facilities, increased regulation
and tighter and more costly capital markets for both healthcare operating and
financing companies. These factors have caused investment spreads to tighten and
have caused a significant decline in the growth rate in the assisted living and
nursing home industries. Therefore, a decision has been made to reduce the
Companies' investment in healthcare assets and focus its resources on its
lodging division.
DIVIDEND
The board of directors of Meditrust Corporation has suspended the payment of its
common share dividend. In evaluating the decision, the board noted that
suspending the dividend will provide additional liquidity of approximately $65
million per quarter compared to its 1999 dividend level. These additional funds
will be used for debt repayment or future disciplined lodging investments
consistent with the Companies plan of reorganization.
The board expects that in December 2000, it will declare the minimum dividend
required to maintain REIT status, which will equal 90% of Meditrust
Corporation's ordinary taxable income for the year ending December 31, 2000. The
timing and amount of the sales of the healthcare assets as well as the operating
results of both the healthcare and lodging divisions, during the year 2000, will
impact any minimum dividend required to maintain REIT status. The board also
noted that the dividend for the Series A preferred stock remains at 9% and will
continue to be declared and paid quarterly.
DEBT REPAYMENT
The funds generated from the sale of the healthcare assets and the available
funds from the suspension of the dividend are intended to repay a significant
amount of Meditrust debt to substantially deleverage the Companies' balance
sheet. Meditrust has approximately $210 million in debt that matures in 2000 and
approximately $1.4 billion in debt that matures in 2001. Meditrust noted that it
intends to repay $210 million of term debt that matures in July 2000 through a
combination of availability of its revolving credit facility and the proceeds
from the sale of assets. As previously announced on December 30, 1999, the
companies repaid $250 million of its term debt that would have otherwise matured
on January 17, 2000.
FUTURE DISCIPLINED LODGING INVESTMENT
As part of its plan of reorganization, Meditrust intends to focus on enhancing
the long-term growth potential of its lodging division. Although La Quinta
continues to be impacted by the supply/demand imbalance, the boards believe that
by focusing on internal growth and improving the efficiency of operations, the
lodging division will be positioned to benefit from improving industry trends
when the supply/demand imbalance begins to moderate. Given the long-term upside
potential in the sector, when deemed appropriate, some of the funds generated
from the healthcare divestitures and dividend suspension will be targeted for
the disciplined investment in the lodging division.
<PAGE>
MANAGEMENT
The Companies also announced that consistent with the adoption of the plan to
reduce its emphasis on the healthcare division, David F. Benson will be leaving
as chief executive officer, president, and treasurer of Meditrust Corporation.
Mr. Benson will continue to assist the Companies on a consulting basis as the
Companies move forward to implement their plan of reorganization. William G.
Byrnes, a member of the board of directors of Meditrust Operating Company, will
act as a transitional chief executive officer of Meditrust Corporation. Clive
Bode remains chairman of the boards of directors of The Meditrust Companies.
Clive Bode, chairman of The Meditrust Companies, said, "During David's 15-year
tenure he contributed greatly to the growth of the healthcare division. We look
forward to his continued efforts, guidance and perspective in his consulting
role to the Companies."
The Meditrust Companies' boards of directors are continuing their search for
candidates with significant lodging industry experience to fill the position of
chief executive officer in the reorganized Meditrust Companies and are working
with a professional search firm to assist in this process.
The Meditrust Companies, headquartered in Needham, Massachusetts, consists of
Meditrust Corporation, a REIT, and Meditrust Operating Company.
* * *
CERTAIN MATTERS DISCUSSED WITHIN THIS PRESS RELEASE MAY CONSTITUTE
"FORWARD-LOOKING STATEMENTS" WITHIN THE MEANING OF THE FEDERAL SECURITIES LAWS.
ALTHOUGH THE MEDITRUST COMPANIES BELIEVE THE STATEMENTS ARE BASED ON REASONABLE
ASSUMPTIONS, IT CAN GIVE NO ASSURANCE THAT ITS EXPECTATIONS WILL BE ATTAINED.
ACTUAL RESULTS AND THE TIMING OF CERTAIN EVENTS COULD DIFFER MATERIALLY FROM
THOSE PROJECTED IN OR CONTEMPLATED BY THE FORWARD-LOOKING STATEMENTS DUE TO A
NUMBER OF FACTORS, INCLUDING, WITHOUT LIMITATION, GENERAL ECONOMIC AND REAL
ESTATE CONDITIONS, SATISFACTION OF CERTAIN CONDITIONS TO THE TRANSACTION, THE
CONDITIONS OF THE CAPITAL MARKETS IN GENERAL AND AT THE TIME OF THE PROPOSED
SPIN-OFF OF THE HEALTHCARE DIVISION, THE IDENTIFICATION OF SATISFACTORY
PROSPECTIVE BUYERS FOR CERTAIN ASSETS AND THE AVAILABILITY OF FINANCING FOR SUCH
PROSPECTIVE BUYERS, THE AVAILABILITY OF FINANCING FOR THE COMPANIES' CAPITAL
INVESTMENT PROGRAM, INTEREST RATES, THE FINANCIAL CONDITION OF THE OPERATORS, OF
MEDITRUST CORPORATION'S HEALTHCARE ASSETS, COMPETITION FOR HOTEL SERVICES AND
HEALTHCARE FACILITIES IN A GIVEN MARKET, THE ENACTMENT OF LEGISLATION FURTHER
IMPACTING THE COMPANIES' STATUS AS A PAIRED SHARE REIT OR MEDITRUST
CORPORATION'S STATUS AS A REIT, THE IMPLEMENTATION OF REGULATIONS IMPACTING
MEDITRUST CORPORATION'S HEALTHCARE BUSINESS, INCLUDING REGULATIONS GOVERNING
PAYMENTS TO OPERATORS OF HEALTHCARE FACILITIES, UNANTICIPATED DELAYS OR EXPENSES
ON THE PART OF
<PAGE>
THE COMPANIES OR THEIR SUPPLIERS IN ACHIEVING YEAR 2000 COMPLIANCE, AND OTHER
RISKS DETAILED FROM TIME TO TIME IN THE FILINGS OF MEDITRUST CORPORATION AND
MEDITRUST OPERATING COMPANY WITH THE SECURITIES AND EXCHANGE COMMISSION,
INCLUDING THE JOINT ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31,
1998 AND OTHER PERIODIC FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS
AMENDED.
<PAGE>
<PAGE>
EXHIBIT 99.2
January 28, 2000
Mr. David F. Benson
24 Middleton Road
Boxford, Massachusetts 01921
Dear David:
This letter agreement (the "Agreement") confirms the agreement that we
have reached regarding your departure from your employment and all offices you
hold with Meditrust Operating Company, Meditrust Corporation, and their related
and affiliated entities (collectively "Meditrust" or the "Companies").
The purpose of this Agreement is to establish mutually agreeable
arrangements for terminating the Employment Agreement made and entered into as
of January 1, 1999 by and between you and Meditrust Corporation (the "Employment
Agreement") and for otherwise modifying your relationship with the Companies.
This Agreement does not constitute and should not be construed as an admission
by you or the Companies that you or they have in any way violated any legal
obligation owed to each other or to any other person. To the contrary, the
parties' willingness to enter into this Agreement demonstrates that they are
continuing to deal with each other fairly and in good faith.
With those understandings and in exchange for the promises set forth
below, you and the Companies agree as follows:
1. SEPARATION
You hereby confirm your separation from Meditrust as an employee
effective as of the Separation Date. You also confirm your resignation from your
office of Chief Executive Officer of Meditrust and any and all employment,
offices and board of directors seats that you may hold with any of the Companies
as of the Separation Date and said resignations are hereby accepted by the
Companies (your separation as an employee and your resignation from your offices
and directorships shall be referred to hereinafter as the "Separation"). In
addition, if requested by the Companies, you agree to resign as a director of
NHP Plc. For purposes of this Agreement, the Separation Date
is February 1, 2000.
<PAGE>
2. COMPENSATION AND BENEFITS
a. SEVERANCE PAYMENT. Within five (5) business days following
the Effective Date (as defined in Section 13(c) below), the Companies shall make
a severance payment to you equal to $8,995,000 in cash and 155,000 paired shares
of stock of the Companies (which shares represent the vesting of previously
awarded performance shares). The cash portion of the severance payment shall be
reduced by applicable withholding.
b. BENEFITS CONTINUATION. For five (5) years from the
Separation Date, you may continue to participate in the group health and dental
plans and in the life and disability insurance plans in which, and to the same
extent as, you are currently participating, with the cost of the regular premium
for such benefit paid by the Companies, provided that each insurer providing
such plans consents to this benefits continuation provision, and to the extent
any particular continuation of benefits cannot be provided because of a lack of
consent by that particular insurer, you and the Companies will cooperate to
convert the particular benefit to an individual plan, and the Companies will pay
the cost of the premiums associated therewith until the earlier of (i) the
expiration of the benefits continuation period or (ii) the date on which you are
able to obtain such benefits through another employer; PROVIDED FURTHER, that
nothing in this Paragraph shall be construed to affect you or your dependents'
rights thereafter to receive continuation coverage to the extent authorized by
and consistent with 29 U.S.C. ss.1161, et. seq. (commonly known as "COBRA") and
applicable group health and dental plan terms, entirely at your own cost after
your right to benefit continuation ends under this Paragraph. In addition, you
will be provided with an automobile allowance for four (4) years at a level
which is not less than the level provided to you immediately prior to the
Separation Date, and you will reimburse the Companies for all future expenses
relating to the leased automobile previously provided to you by the Companies
throughout the term of the lease.
c. OTHER BENEFITS OR COMPENSATION. Except as expressly
provided above, your eligibility to participate in any of the Companies'
respective employee benefit plans and programs ceases on or after the Separation
Date in accordance with the terms and conditions of each of those benefit plans
and programs, and your rights to accrued benefits, if any, under any such
employee benefit plans and programs as of the Separation Date are governed by
the terms and conditions of each of those employee benefit plans and programs
which are incorporated herein by reference. You acknowledge that you received
your base salary and all other compensation due to you through the Separation
Date.
3. RELEASE OF CLAIMS
a. RELEASE BY MR. BENSON. You voluntarily and irrevocably
release and discharge the Companies, their related or affiliated entities, and
their respective predecessors, successors, and assigns, and the current and
former officers, directors, shareholders, employees, and agents of each of the
foregoing (any and all of which are referred to as "Releasees") generally from
all charges, complaints, claims, promises, agreements, causes of
<PAGE>
action, damages, and debts that relate in any manner to your employment with or
termination of employment from the Companies, known or unknown, which you have,
claim to have, ever had, or ever claimed to have had against any of the
Releasees through the date on which you execute this Agreement. This general
release includes, without implication of limitation, all claims for or related
to: the Employment Agreement; the compensation provided to you by the Companies;
your resignations as described in Section 1; wrongful or constructive discharge;
breach of contract; breach of any implied covenant of good faith and fair
dealing; tortious interference with advantageous relations; intentional or
negligent misrepresentation, fraud or deceit; infliction of emotional distress,
and unlawful discrimination under the common law or any statute (including,
without implication of limitation, the Employee Retirement Income Security Act,
Title VII of the Civil Rights Act of 1964, the American with Disabilities Act,
the Age Discrimination in Employment Act or Mass. G.L. c.151B). You also waive
any claim for reinstatement, severance (except as expressly provided in this
Agreement), incentive or retention pay, attorney's fees, or costs, relating to
the above waived claims.
You further agree that you will not hereafter pursue any claim against
any Releasee by filing a lawsuit in any local, state or federal court for or on
account of anything which has occurred up to the present time as a result of
your employment, and you shall not seek reinstatement with, or damages of any
nature, severance, incentive or retention pay, attorney's fees, or costs from
the Companies or any of the other Releasees; PROVIDED, however, that nothing in
this general release shall be construed to bar or limit your on-going rights, if
any, to indemnification subject to and in accordance with the terms of the
By-Laws of the Companies and the Indemnification Agreements, dated as of
November 5, 1997, by and among you and Meditrust Corporation and Meditrust
Operating Company (the "Indemnification Agreements"), or as otherwise might
exist under applicable law, or to enforce your rights under this Agreement.
b. RELEASE BY THE COMPANIES. The Companies, on behalf of
themselves and their respective predecessors, successors, assigns, directors
(but only in their capacities as directors of the Companies) and officers (but
only in their capacities as officers of the Companies) voluntarily and
irrevocably release and discharge you and your successors, assigns, heirs and
survivors from any and all charges, complaints, claims, promises, agreements,
causes of action, damages and debts which any of them have, claim to have, ever
had or ever claimed to have had against you through the date hereof, known or
unknown, which relate to good faith acts or omissions by you during the course
of your employment undertaken or not undertaken in the reasonable belief that
such acts or omissions were in the best interests of the Companies.
<PAGE>
4. EMPLOYMENT AGREEMENT
This Agreement supersedes all provisions of the Employment Agreement
other than Sections 5.1(b) and 5.2, and the last sentence of Section 4.3 and
Schedule 1 thereof, which are incorporated herein by reference and which
shall continue to bind the parties in accordance with their terms. In the
event that any payment made pursuant to this Agreement is determined to be a
so-called change of control or parachute payment for taxation purposes, the
Companies agree that they shall be liable for the payment of the gross-up
provided for in Schedule 1 to the Employment Agreement as if that Schedule 1
were fully applicable to this Agreement.
5. CONSULTING SERVICES
a. You hereby agree to provide non-exclusive consulting
services to the Companies for a period of ten (10) months up to an average of
100 hours per month commencing immediately following the Separation (the
"Consulting Period").
b. In your capacity as a consultant to the Companies, you
agree upon reasonable request from one or more of the Companies to assist with
respect to transitional matters that may arise following your separation, to
respond to requests for assistance or information concerning business matters
with which you became familiar while employed, and to provide assistance with
respect to matters relating to the sale of healthcare assets and the negotiation
and/or renegotiation of the debt structure of the Companies.
c. It is intended and agreed by and between the parties that
while providing consulting services, you are, and shall at all times be and
remain an independent contractor. You understand and agree that during the
Consulting Period, you are not an employee of any of the Companies and shall not
be treated as an employee for any purpose. You understand and agree that as an
independent contractor, you are required to pay and are solely liable for, all
applicable taxes, including, without limitation, federal income tax and state
income tax on remuneration you receive in exchange for the Consulting Services
and you may be required to pay quarterly estimated income taxes. In payment for
your availability to serve as a consultant to the Companies and in payment for
any consulting services actually rendered, the Companies shall pay at the start
of the Consulting Period a retainer fee equal to $400,000 (the "Consulting
Fee"). The Companies also shall promptly reimburse you for all reasonable
disbursements incurred by you in connection with providing consulting services,
subject to approval (which shall not be unreasonably withheld) and documentation
in accordance with applicable policies as may be in effect from time to time. As
needed in connection with your consulting services, the Companies will provide
you with your existing office space and suitable equipment and support staff.
<PAGE>
6. RETURN OF PROPERTY
All documents, records, material and all copies of any of the foregoing
pertaining to confidential information (as described in Section 5.2 of the
Employment Agreement), and all software, equipment (excluding only the cellular
telephone, computer and printer, and fax machine currently in your possession),
and other supplies, whether or not pertaining to confidential information, that
have come into your possession or been produced by you in connection with your
employment ("Property") have been and remain the sole property of the Companies.
You hereby confirm that you have returned all Property to the Companies. In no
event should this provision be construed to require you to return to the Company
any document or other materials concerning your remuneration and benefits during
your employment with the Companies. Your obligations hereunder with respect to
the return of Property shall extend through and be applicable at the conclusion
of the Consulting Period set forth in Paragraph 5 above.
7. LITIGATION COOPERATION
You agree to continue to serve the Companies as a litigation consultant
and, in connection therewith, to cooperate fully with the Companies in (i) the
defense or prosecution of any claims or actions which already have been brought
or which may be brought in the future against or on behalf of the Companies and
(ii) responding to, cooperating with, or contesting any governmental audit,
inspection, inquiry, proceeding or investigation, which relate to events or
occurrences that transpired during your employment with any of the Companies.
Your full cooperation in connection with such claims or actions shall include,
without implication of limitation: promptly notifying the Companies in writing
of any subpoena, interview, investigation, request for information, or other
contact concerning events or occurrences that transpired during your employment
with any of the Companies; being available to meet with counsel for any of the
Companies to prepare for discovery or trial; to testify truthfully as a witness
when reasonably requested and at reasonable times designated by the Companies;
and to meet with counsel or other designated representatives of the Companies;
to prepare responses to and to cooperate with the Companies' processing of
governmental audits, inspections, inquiries, proceedings or investigations. The
Companies agree to reimburse you for any reasonable out-of-pocket expenses,
including reasonable attorneys' fees, that you incur in connection with such
cooperation, subject to reasonable documentation. The Companies will in good
faith exercise their rights under this Section so as not to interfere
unreasonably with your personal schedule or ability to engage in gainful
employment.
In furtherance of your obligations under this Agreement, you agree that
you shall not disclose, provide or reveal, directly or indirectly, any
information concerning the Companies, including without implication of
limitation, their respective operations, plans, strategies or administration, to
any other person or entity unless compelled to do so (a) pursuant to a valid
subpoena or (b) as otherwise required by law, but in either case only after
providing the Companies, through Meditrust Corporation's General Counsel, with
prior written notice and opportunity to contest such subpoena or other
requirement. Written notice shall be provided to
<PAGE>
the Meditrust Corporation's General Counsel as soon as practicable, but in no
event less than five (5) business days before any such disclosure is compelled,
or, if later, one (1) business day after you receive notice compelling such
disclosure.
8. NONDISPARAGEMENT
a. You agree not to take any action or make any statement,
written or oral, which disparages the Companies, their respective officers, or
management and business practices, or which disrupts or impairs the Companies'
normal operations. The provisions of this Section 8 shall not apply to any
truthful statement required to be made by you in any legal proceeding, required
filing under the securities laws, or pursuant to any governmental or regulatory
investigation.
b. The Companies agree that they and their officers and
directors will not take any action or make any statement, written or oral, which
disparages you. The provisions of this Section 8 shall not apply to any truthful
statement required to be made by the Companies in any legal proceeding, required
filing under the securities laws, or pursuant to any governmental or regulatory
investigation.
c. A breach by either you or the Companies of any obligations
under this Section 8 shall not be deemed a material breach of this Agreement and
shall not excuse you or the Companies from performing each of your respective
obligations under this Agreement. The sole remedies for a violation of this
Section 8 shall be an action for damages caused by any such violation and/or to
enjoin any further breach of the obligations of Section 8.
9. ADDITIONAL REPRESENTATIONS, WARRANTIES AND COVENANTS
As a material inducement to the Companies to enter into this Agreement,
you represent, warrant and covenant that: (a) you have not assigned to any third
party any claim released by this Agreement; and (b) you have not heretofore
filed with any agency or court any claim released by this Agreement.
10. FURTHER ASSURANCES
Upon the terms and subject to the conditions herein provided, each of
the signatories hereto agrees to use its reasonable efforts to take, or cause to
be taken, all action and to do, or cause to be done, all things necessary,
proper or advisable under applicable laws and regulations to consummate and make
effective the transactions contemplated by this Agreement. The Companies agree
that the payment and indemnification obligations hereunder are the
responsibility of Meditrust Corporation, the performance of which obligations is
guaranteed by Meditrust Operating Company.
<PAGE>
11. EXCLUSIVITY
This Agreement sets forth all the consideration to which you are
entitled by reason of the Separation, and you shall not be entitled to or
eligible for any payments or benefits under any other severance, equity, bonus,
retention or incentive policy, arrangement or plan of the Companies.
12. CONSENT TO JURISDICTION
To the extent that any court action is permitted consistent with or to
enforce this Agreement, the signatories hereby consent to the jurisdiction of
the state and federal courts in Massachusetts. Accordingly, with respect to any
such court action, the parties hereto (a) submit to the personal jurisdiction of
such courts; (b) consent to service of process; and (c) waive any other
requirement (whether imposed by statute, rule of court, or otherwise) with
respect to personal jurisdiction or service of process. You acknowledge that
your obligations under Sections 5.1(b) and 5.2 of the Employment Agreement are
special, unique and extraordinary, and any breach thereof shall be deemed
material and to cause irreparable injury not properly compensated by damages in
an action at law. You further acknowledge and agree that the Companies' rights
and remedies shall therefore be enforceable both at law and in equity, by
injunction and otherwise.
13. NOTICES, ACKNOWLEDGMENTS AND OTHER TERMS
a. The Companies advised you to consult with an attorney
before signing this Agreement and you acknowledge that you have done so.
b. You acknowledge and agree that the Companies' promises in
this Agreement constitute consideration in addition to anything of value to
which you are otherwise entitled by reason of your separation from employment.
c. You acknowledge that you have been given the opportunity,
if you so desire, to consider this Agreement for twenty-one (21) days before
executing it. If not signed by you and returned to the General Counsel of
Meditrust so that it is received by close of business on the twenty-second
(22nd) day after your receipt of the Agreement, this Agreement will not be
valid. In addition, if you breach any of the conditions of the Agreement within
the twenty-one (21) day period prior to execution of this Agreement, the offer
of this Agreement will be withdrawn and your execution of the Agreement will not
be valid. In the event that you execute and return this Agreement within
twenty-one (21) days or less of the date of its delivery to you, you acknowledge
that such decision was entirely voluntary and that you had the opportunity to
consider this letter agreement for the entire twenty-one (21) day period. The
Companies acknowledge that for a period of seven (7) days from the date of the
execution of this Agreement, you shall retain the right to revoke this Agreement
by written notice delivered to the General Counsel of Meditrust before the end
of such period, and that this Agreement shall not become effective or
enforceable until the expiration of such revocation period (the "Effective
Date").
<PAGE>
d. By signing this Agreement, you acknowledge that you are
doing so voluntarily and knowingly, fully intending to be bound by this
Agreement. You also acknowledge that you are not relying on any representations
by the Companies or any other representative of the Companies concerning the
meaning of any aspect of this Agreement. You understand that this Agreement
shall not in any way be construed as an admission by the Companies of any
liability or any act of wrongdoing whatsoever by the Companies against you and
that the Companies specifically disclaim any liability or wrongdoing whatsoever
against you on the part of themselves and their respective officers, directors,
shareholders, employees and agents. You understand that if you do not enter into
this Agreement and bring any claims against the Companies, the Companies will
dispute the merits of those claims and contend that they acted lawfully and for
good business reasons with respect to you.
e. In the event of any dispute, this Agreement will be
construed as a whole, will be interpreted in accordance with its fair meaning,
and will not be construed strictly for or against either you or the Companies.
f. The law of the Commonwealth of Massachusetts will govern
any dispute about this Agreement, including any interpretation or enforcement of
this Agreement.
g. In the event that any provision or portion of a provision
of this Agreement shall be determined to be illegal, invalid or unenforceable,
the remainder of this Agreement shall be enforced to the fullest extent possible
and the illegal, invalid or unenforceable provision or portion of a provision
will be amended by a court of competent jurisdiction to reflect the signatories'
intent if possible. If such amendment is not possible, the illegal, invalid or
unenforceable provision or portion of a provision will be severed from the
remainder of this Agreement and the remainder of this Agreement shall be
enforced to the fullest extent possible as if such illegal, invalid or
unenforceable provision or portion of a provision was not included.
h. This Agreement may be modified only by a written agreement
signed by an authorized representative of the Companies and all of the other
parties hereto.
i. This Agreement constitutes the entire agreement between
the signatories with respect to the subject matter hereof and supersede all
prior agreements between the parties with respect to any related subject
matter; PROVIDED that Sections 5.1(b) and 5.2, the last sentence of Section
4.3 and Schedule 1 of the Employment Agreement and the Indemnification
Agreements shall remain in full force and effect in accordance with their
terms.
j. This Agreement shall be binding upon each of the
signatories and upon their respective heirs, administrators, representatives,
executors, successors and assigns, and shall inure to the benefit of each party
and to their heirs, administrators, representatives, executors, successors, and
assigns.
14
<PAGE>
k. You will not disclose the fact or terms of this Agreement
to anyone except to your counsel, your financial advisors, and members of your
immediate family until the Companies make public disclosure of the fact and
terms of this Agreement.
l. This Agreement may be executed in counterparts, each of
which shall be deemed an original and all of which together shall constitute one
and the same instrument.
14. INDEMNIFICATION
Nothing in this Agreement shall be construed to limit your ongoing
rights, if any, to indemnification subject to and in accordance with the terms
of the By-Laws of the Companies or the Indemnification Agreements or as might
otherwise exist under applicable law.
15
<PAGE>
If you agree to these terms, please sign and date below and return
this Agreement to the General Counsel of Meditrust Corporation.
Sincerely,
MEDITRUST OPERATING COMPANY
By: /s/ WILLIAM C. BAKER
-----------------------------
President
MEDITRUST CORPORATION
By: /s/ MICHAEL S. BENJAMIN
----------------------------
Senior Vice President & General Counsel
Accepted and agreed to:
/s/ DAVID F. BENSON JANUARY 28, 2000
- ----------------------- ----------------------------------
David F. Benson Date
